Public Health Action is the peer-reviewed open access journal of The International Union Against Tuberculosis and Lung Disease. It communicates and reports new knowledge across all relevant areas of operational research including: infection control, nutrition, TB, HIV, vaccines, smoking, COVID-19, microbial resistance and disease outbreaks.

When it comes to tuberculosis (TB), men and boys bear the highest disease burden, accounting for 64% of all TB cases in 2020. But this single statistic does not capture the full impact of the disease.

The Sentinel Project on Pediatric Drug-Resistant Tuberculosis releases a guide meant to support the care of pregnant and peripartum people with drug-resistant TB and the neonates born to them.

South Africa’s TB testing numbers have recovered from dramatic COVID-19-related declines in 2020, delegates heard at the opening of the 7^th South African TB Conference, held on 13-16 September 2022 in Durban under the theme 'Working together to get TB control back on track'.

A new blood test developed by Tulane University researchers combines nanotechnology with artificial intelligence to diagnose tuberculosis (TB) in children in instances when the deadly disease might otherwise go undetected, according to a study in Nature Biomedical Engineering.

The 72nd session of the World Health Organization (WHO) Regional Committee for Europe, held on 12–14 September 2022 in Tel Aviv, Israel, endorsed TB action plan for the WHO European Region 2023–2030, outlining the vision and strategic actions for the region.

Patients with pulmonary tuberculosis (TB) exhibited an improvement in quality of life and a reduction in treatment costs by utilizing a digital medication event reminder monitor (MERM).

Community monitoring mechanism highlights the gaps in the existing isoniazid preventive therapy program in the country and clearly indicates the high demand for 3HP.

A shortage of TB tests at this critical juncture will be disastrous.

Imagine you have 20 new compounds that have shown some effectiveness in treating a disease like tuberculosis (TB), which affects 10 million people worldwide and kills 1.5 million each year. You know that to treat the disease effectively, patients will need a combination of three or four drugs because TB bacteria behave differently in different environments—and in some cases, evolve to become drug-resistant.